Last reviewed · How we verify
SsK12@Lip@GSH
At a glance
| Generic name | SsK12@Lip@GSH |
|---|---|
| Sponsor | The General Hospital of Western Theater Command |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Streptococcus Salivarius K12@Lip@GSH Alleviates Oral Mucositis in Patients Undergoing Radiotherapy (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SsK12@Lip@GSH CI brief — competitive landscape report
- SsK12@Lip@GSH updates RSS · CI watch RSS
- The General Hospital of Western Theater Command portfolio CI